We are live on
!
Find out more
OCA
OpenArc Corporate Advisory Portfolio holdings
AUM
$8.41B
This Fund
S&P 500
This Quarter
Est. Return
+16.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.41B
AUM Growth
+$1.42B
(+20%)
Cap. Flow
+$539M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44
Avg Time Held
1.6
quarters
Top 10 Avg Time Held
1.6
quarters
Top 20 Avg Time Held
1.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$173M |
| 2 |
Vanguard Russell 1000 Value ETF
VONV
|
+$55.3M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$54M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$34.1M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares A.I. Innovation and Tech Active ETF
BAI
|
+$119M |
| 2 |
TCW Transform Systems ETF
PWRD
|
+$57.9M |
| 3 |
iShares US Financial Services ETF
IYG
|
+$24.4M |
| 4 |
Roper Technologies
ROP
|
+$24.1M |
| 5 |
iShares US Consumer Staples ETF
IYK
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.82% |
| 2 | Technology | 16.24% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Healthcare | 3.98% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
British American Tobacco
BTI
$120B
| $618K | 0.01% |
10,002
+964
| +11% | +$58.2K |
2025 Q4
2 quarters
|
|
427
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $617K | 0.01% |
21,741
+3,313
| +18% | +$94.2K |
2026 Q1
1 quarter
|
|
428
Global Payments
GPN
$21.7B
| $616K | 0.01% |
8,484
-170
| -2% | -$11.7K |
2025 Q4
2 quarters
|
|
429
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $615K | 0.01% |
7,980
+1,186
| +17% | +$87K |
2025 Q4
2 quarters
|
|
430
iShares MSCI EAFE Growth ETF
EFG
$15B
| $614K | 0.01% |
4,937
+921
| +23% | +$111K |
2025 Q4
2 quarters
|
|
431
Viatris
VTRS
$20.1B
| $614K | 0.01% |
38,645
+2,201
| +6% | +$34.1K |
2025 Q4
2 quarters
|
|
432
McKesson
MCK
$111B
| $609K | 0.01% |
806
+68
| +9% | +$53.9K |
2025 Q4
2 quarters
|
|
433
BlackRock ETF Trust II iShares AAA CLO Active ETF
CLOA
$2.75B
| $602K | 0.01% |
11,600
+3,582
| +45% | +$186K |
2025 Q4
2 quarters
|
|
434
Vulcan Materials
VMC
$31.8B
| $602K | 0.01% |
2,041
-183
| -8% | -$52.5K |
2025 Q4
2 quarters
|
|
435
General Motors
GM
$72.3B
| $601K | 0.01% |
7,795
+633
| +9% | +$49.7K |
2025 Q4
2 quarters
|
|
436
iShares Core MSCI Total International Stock ETF
IXUS
$58.5B
| $598K | 0.01% |
6,264
+211
| +3% | +$19.8K |
2025 Q4
2 quarters
|
|
437
American Healthcare REIT
AHR
$11.4B
| $597K | 0.01% |
11,439
+151
| +1% | +$7.42K |
2025 Q4
2 quarters
|
|
438
Norfolk Southern
NSC
$71.7B
| $595K | 0.01% |
1,891
+21
| +1% | +$6.47K |
2025 Q4
2 quarters
|
|
439
ORIX
IX
$39.7B
| $589K | 0.01% |
15,476
+3,179
| +26% | +$113K |
2025 Q4
2 quarters
|
|
440
iShares Systematic Alternatives Active ETF
IALT
$5.69B
| $584K | 0.01% |
+20,837
| New | +$585K |
2026 Q2
0 quarters
|
|
441
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.1B
| $582K | 0.01% |
7,008
-1,018
| -13% | -$85K |
2025 Q4
2 quarters
|
|
442
Avantis US Equity ETF
AVUS
$14.8B
| $581K | 0.01% |
4,539
+10
| +0.2% | +$1.23K |
2025 Q4
2 quarters
|
|
443
ProShares Ultra Technology
ROM
$1.39B
| $581K | 0.01% |
3,743
-72
| -2% | -$9.25K |
2026 Q1
1 quarter
|
|
444
ING
ING
$94.4B
| $581K | 0.01% |
18,503
-206
| -1% | -$6.09K |
2025 Q4
2 quarters
|
|
445
Vanguard S&P 500 Growth ETF
VOOG
$28.3B
| $579K | 0.01% |
7,007
+629
| +10% | +$49.9K |
2026 Q1
1 quarter
|
|
446
iShares MSCI ACWI ETF
ACWI
$33.2B
| $578K | 0.01% |
3,683
-1,300
| -26% | -$199K |
2025 Q4
2 quarters
|
|
447
Ventas
VTR
$42.9B
| $572K | 0.01% |
6,442
+1,031
| +19% | +$87.9K |
2025 Q4
2 quarters
|
|
448
Accenture
ACN
$131B
| $570K | 0.01% |
4,577
-493
| -10% | -$85.6K |
2025 Q4
2 quarters
|
|
449
State Street
STT
$48.1B
| $568K | 0.01% |
3,351
-3,623
| -52% | -$559K |
2025 Q4
2 quarters
|
|
450
Marsh
MRSH
$84.2B
| $565K | 0.01% |
3,387
+437
| +15% | +$73K |
2025 Q4
2 quarters
|
|
Similar funds
HCM
MWM
DKCM
IGAM
FLPIM
MAM
AIM
SBH
OpenArc Corporate Advisory's Q2 2026 Portfolio in Review
As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.
- OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
- OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
- OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
- OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
- OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
- OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
- OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.